566.0000 6.30 (1.13%)
NSE Jul 07, 2026 15:29 PM
Volume: 84,945
 

566.00
1.13%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters pledged 5.53% of shares in last quarter. Total pledge stands at 31.57% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended